A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., Kaya A. H., KAYNAR L., ...More

TRANSFUSION AND APHERESIS SCIENCE, vol.57, no.1, pp.27-30, 2018 (SCI-Expanded) identifier identifier identifier


Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microangiopathic hemolytic anemia and thrombocytopenia (MAHAT) associated with multiorgan dysfunction as a result of microvascular thrombosis and tissue ischemia. The differentiation of the etiology is of utmost importance as the pathophysiological basis will dictate the choice of appropriate treatment.